| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP &Chief Accounting Officer
1 company
Thomsen Jillian B. is a Chief Financial Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $20.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 4,016 | $38.25 | $153,612.00 | -2.5% | |
| May 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 3,576 | $83.39 | $298,202.64 | -5.2% | |
| Apr 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sale+OE | 13,881 | $101.46 | $1,408,366.26 | -16.8% | |
| Feb 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 2,545 | $82.94 | $211,082.30 | -3.6% | |
| Aug 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 2,648 | $19.32 | $51,159.36 | -5.0% | |
| May 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 2,651 | $19.55 | $51,827.05 | -4.8% | |
| Mar 20, 2017 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sale+OE | 112,500 | $19.69 | $2,215,125.00 | -66.9% | |
| Feb 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 1,965 | $13.14 | $25,820.10 | -3.4% | |
| Nov 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 1,986 | $13.96 | $27,724.56 | -4.5% | |
| Aug 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Accounting Officer | Sell | 3,971 | $17.56 | $69,730.76 | -8.3% |